Clinical Trial Update: Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant and adjuvant exemestane for postmenopausal women with locally advanced hormone receptor-positive breast cancer has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Stage Iiia Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: Robert H. Lurie Cancer Center | Conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer | Phase 2 | Status: WITHDRAWN